The WSE Management Board to Launch Futures Contracts on Diagnostyka S.A. Shares as of 30 June 2025
The Management Board of the Warsaw Stock Exchange (WSE) has decided to introduce futures contracts on the shares of Diagnostyka S.A. The instruments will be available for trading starting from the stock exchange session on 30 June 2025.
Three series of futures contracts on Diagnostyka shares will be listed, with different expiry dates: September and December 2025, and March 2026. Each contract will cover 100 shares of the Company.
The introduction of futures contracts on Diagnostyka shares marks an important step in further strengthening the Company’s presence on the capital market. We see this as a confirmation of investor trust and the growing significance of Diagnostyka among the largest listed companies.
Futures contracts on shares are derivative instruments traded on the WSE, with their value based on the market quotations of selected listed companies. The WSE introduces these instruments exclusively for selected, large, and highly liquid companies that meet strict criteria regarding market capitalization and trading volume. Inclusion in this segment of the market confirms a company’s strong position and the trust it enjoys among capital market participants.
Go back to homepage
